Get started

Financials · OGN

Organon & Co. (OGN) financials

For the twelve months ended Sep 30, 2026, Organon & Co. reported $6.10B of revenue and $213.00M of net income.

Revenue, TTM
$6.10B
Revenue growth, YoY
-3.2%
Net income, TTM
$213.00M
Net income growth, YoY
-57.5%
Net margin
3.5%
Free cash flow, TTM
$675.00M
EPS, diluted, TTM
$0.77
EPS growth, YoY
-59.9%
Cash
$1.46B
Total debt
$8.55B
P/E
17.08
P/S
0.60
Market cap
$3.64B
Annual revenue$6.22B
FY2019FY2025
Annual net income$187.00M
FY2019FY2025
Annual free cash flow$538.00M
FY2019FY2025

OGN revenue and earnings growth

OGN revenueQ3 2026$1.57B

Quarter YoY
-1.7%
QoQ
+1.0%
FY YoY
-2.9%
5Y CAGR
-1.0%

OGN revenue was $1.57B in fiscal Q3 2026 (ended Sep 30, 2026), down 1.7% from a year earlier and up 1.0% from the prior quarter. For the full fiscal 2025 it was $6.22B, down 2.9% from fiscal 2024. Compound annual growth was -1.0% over 5 years. It rose in 2 of the last 6 fiscal years.

OGN net incomeQ3 2026$164.00M

Quarter YoY
+2.5%
QoQ
+51.9%
FY YoY
-78.4%
5Y CAGR
-38.7%

OGN net income was $164.00M in fiscal Q3 2026 (ended Sep 30, 2026), up 2.5% from a year earlier and up 51.9% from the prior quarter. For the full fiscal 2025 it was $187.00M, down 78.4% from fiscal 2024. Compound annual growth was -38.7% over 5 years. It rose in 1 of the last 6 fiscal years.

OGN EPSQ3 2026$0.60

Quarter YoY
-1.6%
QoQ
+50.0%
FY YoY
-78.4%
5Y CAGR
-39.0%

OGN diluted EPS was $0.60 in fiscal Q3 2026 (ended Sep 30, 2026), down 1.6% from a year earlier and up 50.0% from the prior quarter. For the full fiscal 2025 it was $0.72, down 78.4% from fiscal 2024. Compound annual growth was -39.0% over 5 years.

OGN free cash flowQ3 2026$326.00M

Quarter YoY
+49.5%
QoQ
+401.5%
FY YoY
-29.6%
5Y CAGR
-23.3%

OGN free cash flow was $326.00M in fiscal Q3 2026 (ended Sep 30, 2026), up 49.5% from a year earlier and up 401.5% from the prior quarter. For the full fiscal 2025 it was $538.00M, down 29.6% from fiscal 2024. Compound annual growth was -23.3% over 5 years. It rose in 1 of the last 6 fiscal years.

Export CSV

Income statement

Income statement
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
Revenue$6.22B$6.40B$6.26B$6.17B$6.30B$6.53B$7.78B
Cost of revenue$2.90B$2.69B$2.52B$2.29B$2.38B$2.12B$2.27B
Gross profit$3.31B$3.71B$3.75B$3.88B$3.92B$4.41B$5.50B
Research and development$366.00M$469.00M$528.00M$471.00M$339.00M$210.00M$220.00M
Selling, general and admin$1.72B$1.76B$1.89B$1.70B$1.67B$1.36B$1.44B
Interest expense$504.00M$520.00M$527.00M$422.00M$258.00M$0$0
Pre-tax income$425.00M$807.00M$673.00M$1.12B$1.53B$2.75B$3.70B
Income tax$238.00M-$57.00M-$350.00M$205.00M$178.00M$496.00M$390.00M
Net income$187.00M$864.00M$1.02B$917.00M$1.35B$2.16B$3.22B
EPS, basic$0.72$3.36$4.01$3.61$5.33$8.52$12.69
EPS, diluted$0.72$3.33$3.99$3.59$5.31$8.52$12.69
Diluted shares260.8M259.2M256.3M255.2M254.2M253.5M253.5M

Balance sheet

Balance sheet
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
Cash and equivalents$574.00M$675.00M$693.00M$706.00M$737.00M$12.00M$0
Receivables$1.33B$1.36B$1.74B$1.48B$1.38B$1.04B-
Inventory$1.41B$1.32B$1.31B$1.00B$915.00M$913.00M-
Current assets$4.35B$4.35B$4.51B$3.93B$3.76B$3.57B-
Goodwill$4.15B$4.68B$4.60B$4.60B$4.60B$4.60B-
Total assets$12.87B$13.10B$12.06B$10.96B$10.68B$10.11B-
Current liabilities$2.39B$2.72B$2.92B$2.51B$2.60B$2.67B-
Short-term debt$16.00M$20.00M$9.00M$8.00M$9.00M$0-
Long-term debt$8.63B$8.86B$8.75B$8.90B$9.13B$0-
Total debt$8.64B$8.88B$8.76B$8.91B$9.13B$0-
Total liabilities$12.12B$12.63B$12.13B$11.85B---
Shareholders' equity$752.00M$472.00M-$70.00M-$892.00M-$1.51B$5.49B$7.04B

Cash flow

Cash flow
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
Operating cash flow$700.00M$939.00M$799.00M$858.00M$2.16B$2.28B$3.02B
Capital expenditures$162.00M$175.00M$251.00M$196.00M$192.00M$255.00M$92.00M
Free cash flow$538.00M$764.00M$548.00M$662.00M$1.97B$2.03B$2.93B
Investing cash flow-$390.00M-$513.00M-$260.00M-$420.00M-$481.00M-$250.00M-$88.00M
Financing cash flow-$561.00M-$368.00M-$569.00M-$433.00M-$977.00M-$2.02B-$2.93B
Dividends paid$88.00M$297.00M$294.00M$290.00M$145.00M$0$0
Stock-based compensation$77.00M$105.00M$101.00M$75.00M$59.00M$40.00M$41.00M

Key ratios

Key ratios
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
Revenue growth, YoY-2.9%2.2%1.4%-2.1%-3.5%-16.0%-
Net income growth, YoY-78.4%-15.5%11.6%-32.1%-37.5%-32.9%-
EPS growth, YoY-78.4%-16.5%11.1%-32.4%-37.7%-32.9%-
Gross margin53.3%58.0%59.8%62.8%62.2%67.6%70.8%
Net margin3.0%13.5%16.3%14.9%21.4%33.1%41.4%
Free cash flow margin8.7%11.9%8.7%10.7%31.2%31.1%37.6%
Return on equity24.9%183.1%---39.4%45.7%
Return on assets1.5%6.6%8.5%8.4%12.6%21.4%-
Current ratio1.821.601.541.561.451.33-
Debt to equity11.4918.81---0.00-

Source: XBRL data Organon & Co. files with the SEC, latest filing dated Oct 30, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

OGN peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
OGN$6.10B-3.2%$213.00M3.5%$3.64B
LLY$86.46B+45.5%$27.58B31.9%$1.33T
JNJ$99.33B+7.8%$16.09B16.2%$679.13B
ABBV$66.01B+10.7%$10.34B15.7%$518.44B
MRK$67.38B+4.9%$2.45B3.6%$366.73B
NVS$54.53B+8.4%$13.98B25.6%$312.35B
AZN$58.74B+8.6%$10.22B17.4%$293.69B
ABT$48.23B+10.0%$4.70B9.7%$191.40B
NVODKK 309.06B+6.4%DKK 102.43B33.1%$183.23B

OGN FAQ

9 questions
  • What is OGN revenue?
    Organon & Co. (OGN) reported $6.10B of revenue for the twelve months ended Sep 30, 2026. That is down 3.2% from the year before. Revenue for fiscal 2025 was $6.22B.
  • Is OGN profitable?
    Yes. Organon & Co. earned $213.00M in net income for the twelve months ended Sep 30, 2026, a net margin of 3.5%.
  • How much cash and debt does OGN have?
    Organon & Co. reported $1.46B in cash and cash equivalents and $8.55B of debt on its most recent balance sheet in SEC filings.
  • How fast is OGN revenue growing?
    Organon & Co.'s revenue changed -2.9% in fiscal 2025, to $6.22B. Its compound annual growth rate was -1.0% over 5 years.
  • What is OGN gross margin?
    Organon & Co.'s gross profit was $3.24B on $6.10B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 53.1%.
  • What is OGN free cash flow?
    Organon & Co. generated $675.00M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $843.00M less capital expenditures.
  • What is OGN earnings per share?
    Diluted earnings per share were $0.77 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
  • When did OGN last report financial results?
    The latest statements here come from Organon & Co.'s 10-Q filed on Oct 30, 2026, covering the period ended Sep 30, 2026.
  • Where does this OGN financial data come from?
    Quantisnow builds these statements from the structured XBRL data Organon & Co. files with the SEC. It is provided for information only and is not investment advice.